Jun 26, 2026
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $10.93 to $7.81.
The split itself did not change the total investment value.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A (SSE:603811) operates in the Pharmaceuticals: major industry.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A company overviewZhejiang Chengyi Pharmaceutical Co. Ltd. Class A's most recent stock split was on June 26, 2026. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A (SSE:603811) has split its stock 5 times: a 7-for-5 split on November 26, 2018, a 7-for-5 split on June 3, 2020, a 7-for-5 split on June 4, 2021, a 7-for-5 split on June 8, 2023, and a 7-for-5 split on June 26, 2026.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A has split its stock 5 times. This history records 5 forward splits between November 26, 2018 and June 26, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A's 7-for-5 split on June 26, 2026, every 5 shares became 7 shares.
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A has not announced a new split in our records. Its most recent split was on June 26, 2026, less than a year ago. Companies announce splits in advance, and any new SSE:603811 split will appear on this page.
Already premium?